Apalutamide

CHEMBL3183409 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

477.4 g/mol

LogP

3.0

Phase

4

A next-generation androgen receptor inhibitor that blocks the effects of testosterone and other male hormones on prostate cancer cells, slowing their growth and spread. It is approved for non-metastatic and metastatic castration-resistant prostate cancer.

분자량

477.4000 g/mol

LogP

3.00

TPSA

121.00 Å²

리핀스키 5의 법칙

통과

치료 영역

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Non-Small Cell Lung Cancer Melanoma Breast Cancer Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F

InChI

InChI=1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31)

Molecular Formula

C21H15F4N5O2S

HBD / HBA

1 / 9

회전 가능 결합

3

무거운 원자

33

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A next-generation androgen receptor inhibitor that blocks the effects of testosterone and other male hormones on prostate cancer cells, slowing their growth and spread. It is approved for non-metastatic and metastatic castration-resistant prostate cancer.

Yes, Apalutamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3183409. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 24872560. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Apalutamide PillFYI에서

구조

핵심 데이터

분자식: C21H15F4N5O2S
동의어: 1

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.